Qiagen (QGEN:NASDAQ) Investor Relations Material

Overview

Dutch-based biotech company QIAGEN N.V. is revolutionizing the field of molecular biology on a global scale with its "sample to insight" solutions. Boasting a wide range of products and services, QIAGEN is a key player in primary and secondary sample technology consumables, including manual and automated processing for genotyping, gene expression, viral and bacterial analysis, silica membranes, magnetic bead technologies, and nucleic stabilization and purification kits for primary sample materials. The company also offers human ID and forensics assay consumables, food contamination assays, and interferon-gamma release assay for TB testing. But QIAGEN's scope of products goes far beyond just sample processing. The company offers a plethora of assays for prenatal testing, detection of sexually transmitted diseases and HPV, as well as assays for post-transplant testing and viral load monitoring. QIAGEN even provides custom laboratory and genomic services, predefined and custom NGS gene panels, and whole genome amplification. With over 35 years of experience in the industry, QIAGEN's innovative solutions don't stop there. The company also offers sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes and integrated PCR testing. QIAGEN has become a major player in the PCR consumables market, providing quantitative PCR, reverse transcription, and combination kits for analysis of gene expression, genotyping, and gene regulation instruments and technologies. Overall, QIAGEN serves a diverse set of molecular diagnostics, academia, pharmaceutical, and applied testing customers worldwide. Founded in 1986 and headquartered in Venlo, the Netherlands, QIAGEN's comprehensive range of products and services are at the forefront of the industry, transforming biological materials into invaluable molecular insights.

Frequently Asked Questions

What is Qiagen's ticker?

Qiagen's ticker is QGEN

What exchange is Qiagen traded on?

The company's shares trade on the NASDAQ stock exchange

Where are Qiagen's headquarters?

They are based in Hilden, Germany

How many employees does Qiagen have?

There are 1001-5000 employees working at Qiagen

What is Qiagen's website?

It is qiagen.com/us

What type of sector is Qiagen?

Qiagen is in the Healthcare sector

What type of industry is Qiagen?

Qiagen is in the Biotechnology industry

Who are Qiagen's peers and competitors?

The following five companies are Qiagen's industry peers:

- Verona Pharma plc

- ICON Public Company

- Microbix Biosystems Inc.

- Applied Therapeutics, Inc.

- Evofem Biosciences